Dear Friends and Colleagues,
It is with great pleasure to announce and to invite you to join us at The 2nd Asia Pacific Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy - DIPAP Greater China to take place this coming March 16-18, 2018 in Shanghai, China.
The Symposium is held in order to highlight and document scientifically and practically on how to prevent, diagnose and manage HIP to optimize care and outcomes in what is seen as a large knowledge gap within the field. The great success of the previous Ten DIP Symposia held all over Europe and the first in Asia-Pacific in 2016 have paved the way for the Inaugural DIPAP Greater China Symposium. Like the DIP Symposium in Europe, Greater China will aim to raise awareness of the connection between hyperglycemia and poor pregnancy outcomes, where there needs to be a greater global focus on preventing, screening, diagnosing, and managing hyperglycemia in pregnancy.
The DIP Symposium continuously aims to lead a greater global focus on Hypertension in Pregnancy (HIP), maternal and fetal medicine. Doing so by raising awareness of the links between hyperglycemia and poor maternal and fetal outcomes as well as to the future health risks to mother and offspring and demand a clearly defined global health agenda to tackle this issue. To provide guidance for testing, management and care of women with HIP regardless of resource setting as outlined in the FIGO document and to inspire action by showcasing ongoing initiatives on diabetes in pregnancy in the region and globally.
The DIPAP Greater China Symposium will introduce a unique program on “Digital Health” whereby start-up companies, innovative concepts, development of ideas to execution will be brought to the forefront in keynote lectures and demonstrations. A never-before collaboration of Scientific content and hi-tech will meet, listen and discuss on the third day of the Symposium. The Digital Health program will successfully address and highlight the importance of introducing and including digital health within the treatment of Diabetes, Hypertension, Metabolic Syndrome and Pregnancy.
Designated scientific sessions specific to HIP and the specific region is set out to provide in great detail the importance of HIP locally and regionally. It is important for such a course to take place in order to allow participants to receive a great overview of matters concerning their geographical region within a short time frame. The program provides a specific and targeted overview from certain matters of the overall Symposium, allowing it to reach its targeted audience and ideally reach maximum impact in teaching / bringing to light the matters surrounding HIP.
Additionally, controversial topics and use of new technologies in perinatal medicine will be discussed in detail. This will allow participants to formulate a modus operandi through evidence provided by the presenting experts. Innovations connected to perinatal research on Whole Genome Sequencing, NIPT, small RNA's, Metabolomics and Microbiota will be discussed at length at the Symposium. The faculty comprises of renowned professionals and practitioners from all over the world, who will present the most updated clinical and laboratory revolutions, based on evidence as well as practical experience.
We look forward to your participation and hope that you will contribute to the scientific program by submitting your abstracts.
With best wishes and hoping to see you in Shanghai, China!